Lu Peng
No. 106, Zhongshan 2nd Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.
Journal: Molecular immunology
Published: May 29, 2026
Promoting keratinocyte psoriasiform changes and IL-17RE expression: Potential role of GLT1D1 in linear psoriasis.
Journal: Molecular immunology
Published: December 08, 2025
Machine Learning-Driven Prediction Models for Brodalumab Therapeutic Effect and Response Speed in Plaque Psoriasis.
Journal: Psoriasis (Auckland, N.Z.)
Published: May 08, 2025
Enhancing the acoustoelectric conversion of a nanofiber transducer in combination with a kazoo.
Journal: Nanoscale
Published: April 09, 2025
Discovery of Highly Bioactive Peptides through Hierarchical Structural Information and Molecular Dynamics Simulations.
Journal: Journal of chemical information and modeling
Published: October 28, 2024
Correction: Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis.
Journal: Dermatology and therapy
Published: June 04, 2024
IL-17A/F double producing T cells, unstable Tregs and quiescent TRMs in clinically healed lesions are potential cellular candidates for recurrence of psoriasis.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 02, 2024
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis.
Journal: Dermatology and therapy
Published: January 17, 2024
Editorial: Immunometabolism of T cells in skin infection, autoimmunity and cancer biology.
Journal: Frontiers in immunology
Published: June 09, 2023
Skin microbial dysbiosis is a characteristic of systemic drug-related intertriginous and flexural exanthema-like lesions induced by EGFR inhibitor.
Journal: Heliyon
Published: May 27, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026